Monika Pepek

Rzeszow, PK, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Integrated analysis of IGHV rearrangements and cytogenetic abnormalities in a large chronic lymphocytic leukemia cohort (CLL-POL1).

Integrated analysis of IGHV rearrangements and cytogenetic abnormalities in a large chronic lymphocytic leukemia cohort (CLL-POL1).

Journal: BMC cancer

Published: April 28, 2026

Tisa-cel and axi-cel CAR structure influences the development of resistance to CD19-CAR-T therapy.

Tisa-cel and axi-cel CAR structure influences the development of resistance to CD19-CAR-T therapy.

Journal: Leukemia

Published: March 11, 2026

The costimulatory domain influences CD19 CAR-T cell resistance development in B-cell malignancies.

The costimulatory domain influences CD19 CAR-T cell resistance development in B-cell malignancies.

Journal: bioRxiv : the preprint server for biology

Published: March 17, 2025

LILRB1-directed CAR-T cells for the treatment of hematological malignancies.

LILRB1-directed CAR-T cells for the treatment of hematological malignancies.

Journal: Leukemia

Published: September 06, 2024

Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL.

Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL.

Journal: HemaSphere

Published: July 11, 2024

CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies.

CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies.

Journal: Oncoimmunology

Published: June 07, 2024

Clonal medicine targeting DNA damage response eradicates leukemia.

Clonal medicine targeting DNA damage response eradicates leukemia.

Journal: Leukemia

Published: October 09, 2023

The interplay between telomeric complex members and BCR::ABL1 oncogenic tyrosine kinase in the maintenance of telomere length in chronic myeloid leukemia.

The interplay between telomeric complex members and BCR::ABL1 oncogenic tyrosine kinase in the maintenance of telomere length in chronic myeloid leukemia.

Journal: Journal of cancer research and clinical oncology

Published: December 03, 2022

Analysis of Mutational Profile of Hypopharyngeal and Laryngeal Head and Neck Squamous Cell Carcinomas Identifies KMT2C as a Potential Tumor Suppressor.

Analysis of Mutational Profile of Hypopharyngeal and Laryngeal Head and Neck Squamous Cell Carcinomas Identifies KMT2C as a Potential Tumor Suppressor.

Journal: Frontiers in oncology

Published: September 01, 2021

Epithelial Cells of Deep Infiltrating Endometriosis Harbor Mutations in Cancer Driver Genes.

Epithelial Cells of Deep Infiltrating Endometriosis Harbor Mutations in Cancer Driver Genes.

Journal: Cells

Published: March 02, 2021

Predictive significance of selected gene mutations in relapsed and refractory chronic lymphocytic leukemia patients treated with ibrutinib.

Predictive significance of selected gene mutations in relapsed and refractory chronic lymphocytic leukemia patients treated with ibrutinib.

Journal: European journal of haematology

Published: August 26, 2020

Differential Regulation of Telomeric Complex by BCR-ABL1 Kinase in Human Cellular Models of Chronic Myeloid Leukemia-From Single Cell Analysis to Next-Generation Sequencing.

Differential Regulation of Telomeric Complex by BCR-ABL1 Kinase in Human Cellular Models of Chronic Myeloid Leukemia-From Single Cell Analysis to Next-Generation Sequencing.

Journal: Genes

Published: August 08, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026